ArticleFrontiers in medicine2025

Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.

Hai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.